We recently interviewed Henrik Fyrlund, Manager of Advanced Acoustics and the Acoustics Portfolio Lead at Cochlear, to debunk some common myths about active bone conduction systems by discussing the science […]
Proper placement of an electrode array is essential for maximizing postoperative performance outcomes with a cochlear implant. Imaging is typically the standard of care for confirming proper electrode placement; however, […]
Welcome to Cochlear™ Quick Tips. The purpose behind Quick Tips is to give you “bite-sized” information that you can use when working with our products. In this first edition, we […]
[LONE TREE, CO, July 8, 2025]: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of the Cochlear™ […]
Written by Guest Author, Dr. Abby Meyer, MD, MPH, FAAP Congenital cytomegalovirus (cCMV) infection is the most common congenital infection with an estimated prevalence of approximately 1 in 200 births. […]
[LONE TREE, CO] – June 2, 2025: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 Sound […]
Cochlear™ Nucleus® Implant electrode array design is a widely debated topic when it comes to performance and patient outcomes. This Science Spotlight focuses on a study out of Columbia University […]
As we reflect on the past quarter, I am filled with immense pride and gratitude for the remarkable achievements and milestones our community has made. This year marks the 5th […]
Co-authored by Alejandra Ullauri, Au.D, MPH, ABA-CISD. It is well documented that hearing loss makes it more difficult for patients to communicate with their healthcare provider¹. This is complicated even […]
The purpose of this article is to provide professionals with: We take pride in building strong relationships with our customers, ensuring they are seen, heard, and feel valued. We recognize […]
End of content
No more pages to load
